| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/16/2003 | US20030013714 Sleep disorders; eating disorders; sexual disorders; hypotensive agents |
| 01/16/2003 | US20030013708 Therapeutic heterocyclic compounds |
| 01/16/2003 | US20030013702 Agents and methods for treatment of cancer |
| 01/16/2003 | US20030013603 Catalyst for oxidation, carbonylation, nitration, sulfonation |
| 01/16/2003 | US20030012980 Quinoline derivatives and organic electroluminescent devices |
| 01/16/2003 | CA2452592A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 01/15/2003 | EP1275638A1 Combination therapy for the treatment of immunological disorders |
| 01/15/2003 | EP1274700A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 01/15/2003 | EP1274686A1 Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl]proprionic acid |
| 01/15/2003 | EP1274678A1 Novel alpha-sulfin- and alpha-sulfonamido acid amides |
| 01/15/2003 | EP1274457A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 01/15/2003 | CN1391570A Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1098839C Preparation and application of 80-chloroquinolone carboxylic acid derivative |
| 01/14/2003 | US6506907 Process |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506762 Certain alkylene diamine-substituted heterocycles |
| 01/09/2003 | WO2003003008A1 Chemical libraries useful for drug discovery processes |
| 01/09/2003 | WO2003002548A1 A process for the preparation of chiral glucocorticoid receptor agents |
| 01/09/2003 | WO2003002539A1 Dibenzocycloheptene compound |
| 01/09/2003 | WO2003002532A1 Cyclic diamine compounds having fused-ring groups |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003002118A1 Substituted 8-arylquinoline pde4 inhibitors |
| 01/09/2003 | US20030009033 Substituted condensation products of N-benzyl-3-indenylacent amides with heterocyclic aldehydes for neoplasia |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | CA2452105A1 Dibenzocycloheptene compound |
| 01/09/2003 | CA2450686A1 Substituted 8-arylquinoline pde4 inhibitors |
| 01/08/2003 | EP1273571A1 Nitrogenous compounds and antiviral drugs containing the same |
| 01/08/2003 | EP1273330A1 Sublimation purifying method and apparatus |
| 01/08/2003 | EP1272827A1 Analyte detection & apparatus therefor |
| 01/08/2003 | EP1272460A1 Novel alpha-sulfin- and alpha-sulfonamino acid amide derivatives |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
| 01/08/2003 | CN1390122A Tissue factor antagonists and methods of use thereof |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | US6503643 Electro-luminescent arrangements with thiophene carboxylate metal complexes |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/06/2003 | CA2392187A1 Combination preparation for the therapy of immunological diseases |
| 01/03/2003 | WO2003000681A1 Antibacterial having quinolinecarboxamide skeleton |
| 01/03/2003 | WO2003000660A1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 01/03/2003 | WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 01/03/2003 | WO2003000295A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | WO2003000294A1 Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer |
| 01/03/2003 | WO2003000292A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 01/03/2003 | WO2003000247A1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 01/03/2003 | WO2003000175A2 Pediatric formulation of gatifloxacin |
| 01/03/2003 | CA2455288A1 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | CA2454538A1 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same |
| 01/03/2003 | CA2451625A1 Substituted n-acyl-aniline derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 01/03/2003 | CA2450762A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 01/03/2003 | CA2450742A1 Pediatric formulation of gatifloxacin |
| 01/02/2003 | US20030004158 Kinase inhbitor; antiproliferative agents |
| 01/02/2003 | US20030004156 Anticholesterol agents; cardiovascular disorders; antidiabetic agents; antiproliferative agents |
| 01/02/2003 | EP1270549A1 Polymer-immobilized alpha-iminoester |
| 01/02/2003 | EP1268470A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 01/02/2003 | EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP1267874A2 Therapeutic uses of ppar mediators |
| 01/02/2003 | EP0992241B1 Medicinal compositions against helicobacter pylori |
| 01/02/2003 | EP0915859B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/02/2003 | EP0751939B9 Naphthylamides as central nervous system agents |
| 12/31/2002 | US6500956 Method for the catalytic production of substituted bipyridyl derivatives |
| 12/31/2002 | US6500842 N-((4-chlorophenyl)methyl)-8-hydroxy-7-quinolinecarboxamide administered as viricides against herpes virus |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500825 Substituted 2-aminoacetamides and the use thereof |
| 12/31/2002 | US6500819 Has an excellent anxiolytic effect |
| 12/27/2002 | WO2002102780A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 12/27/2002 | WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 12/27/2002 | WO2002009758A3 Inhibitors of cellular efflux pumps of microbes |
| 12/27/2002 | WO2001085095B1 Chiral fluoroquinolizinone arginine salt forms |
| 12/26/2002 | US20020198207 Novel Hexanoic acid derivatives |
| 12/26/2002 | US20020198194 Neuropeptide Y (NPY) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/25/2002 | CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 12/25/2002 | CN1387507A Diaryl-enynes |
| 12/24/2002 | US6498254 Antiretroviral compounds and compositions |
| 12/24/2002 | US6498191 For treatment of alzheimer's disease, diabetes mellitus, parkinson's disease, neuronal and cardiac ischemia, huntington's disease, stroke |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 12/24/2002 | US6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/24/2002 | US6498154 Cyclic regimens using quinazolinone and benzoxazine derivatives |
| 12/19/2002 | WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 12/19/2002 | WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 12/19/2002 | WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/19/2002 | WO2002100825A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances |
| 12/19/2002 | WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
| 12/19/2002 | WO2002100812A1 Carboxylic acid derivative and salt thereof |
| 12/19/2002 | WO2002100410A1 Methods of treating alzheimer's disease |
| 12/19/2002 | WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/19/2002 | WO2002070541A3 Peptide deformylase inhibitors |
| 12/19/2002 | WO2002042248A3 Naphthalene derivatives |
| 12/19/2002 | US20020193591 A 3-dialkylamino-2-(3-methylbenzoyl)acrylic acid derivative; 1,4-dihydro-8-methyl-5-nitro-4-oxoquinoline-3-carboxylic acid derivative as intermediates to 5-amino-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acid |
| 12/19/2002 | US20020193578 Compounds having activity as inhibitors of cytochrome P450RAI |
| 12/19/2002 | US20020193354 7, 9-substituted tetracycline compounds |
| 12/19/2002 | US20020190250 Iridium complexes in electron transport layer of Light-emitting diodes; bright, efficient, stable; low temperature vacuum deposition and preventing decomposition |
| 12/19/2002 | DE10128331A1 New 2-(heteroarylsulfonyl-amino)-benzamide derivatives, which are potassium ion channel blocking antiarrhythmic agents, useful for e.g. treating atrial fibrillation or flutter |
| 12/19/2002 | DE10121003A1 Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Anthranilic acid amides, processes for preparing, their use as a medicament as well as pharmaceutical compositions containing them |
| 12/19/2002 | CA2449948A1 Methods of treating alzheimer's disease |